Holen Sie sich die Stockscreener-App
4.22
1.86%
-0.08
Handel nachbörslich:
4.45
0.23
+5.45%
Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.51%
7.5313
|
8.3229 | 8.5543 | 6.3283 | 7.1694 |
| Operating Income/Loss |
9.51%
-7.5313
|
-8.3229 | -8.5543 | -6.3283 | -7.1694 |
| Nonoperating Income/Loss |
46.68%
0.0846
|
0.1586 | 0.0452 | -0.00976 | 0.0674 |
| Income/Loss Before Equity Method Investments |
12.13%
-7.2349
|
-8.2335 | 45.00 | -6.1622 | -6.2952 |
| Income/Loss From Equity Method Investments |
38.28%
-0.062
|
-0.0448 | -0.0474 | -0.0627 | -0.0426 |
| Income/Loss From Continuing Operations Before Tax |
11.86%
-7.2969
|
-8.2783 | 44.95 | -6.2249 | -6.3378 |
| Income/Loss From Continuing Operations After Tax |
11.86%
-7.2969
|
-8.2783 | 44.95 | -6.2249 | -6.3378 |
|
Net Income/Loss
|
11.86%
-7.2969
|
-8.2783 | -8.1641 | -6.2249 | -6.3378 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
7.05%
-0.0751
|
-0.0808 | -0.0727 | -0.098 | -0.0464 |
| Basic Average Shares |
48.75%
2.8023
|
1.8839 | -2.2948 | 3.7355 | 2.6996 |
| Diluted Average Shares |
48.75%
2.8023
|
1.8839 | -2.2948 | 3.7355 | 2.6996 |
| Basic Earnings Per Share |
40.69%
-2.58
|
-4.35 | -55.49 | -1.64 | -2.33 |
| Diluted Earnings Per Share |
40.69%
-2.58
|
-4.35 | -55.49 | -1.64 | -2.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):